Danaher (NYSE: DHR) reported Q2 EPS of $2.76, $0.40 better than the analyst estimate of $2.36. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.32 billion.

For earnings history and earnings-related data on Danaher (DHR) click here.

Earnings

KeyBanc Remains Positive on Life Sciences as 'Strong' Earning Season Begins with Danaher (DHR) ReportJuly 21, 2022 11:40 AM UBS on Danaher (DHR): 'we believe the CPHD platform will continue to see traction as COVID-19 becomes endemic'July 21, 2022 11:24 AM Cowen Reiterates Outperform Rating on Danaher (DHR), 'We expect the stock to react favorably'July 21, 2022 10:22 AM Stifel Reiterates Hold Rating on Danaher (DHR), 'we are impressed with the company's ability to perform'July 21, 2022 10:21 AM Danaher Reports Second Quarter 2022 ResultsJuly 21, 2022 6:00 AM